Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...

The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults who have had an ...

The decision by drug makers to stop selling such medicines follows decades of investigations and lawsuits against the drugmakers that had marketed the fast-acting painkillers.

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Older adults with long-term benzodiazepine receptor agonist use and insomnia diagnosis had significant improvements in sleep outcomes.

HealthDay News — COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of ...

US health officials have warned for months about a resurgence in breakthrough infections in older children and adults, even though unvaccinated young children and newborns of unvaccinated moms remain ...

The Food and Drug Administration (FDA) has approved Sarclisa ® (isatuximab-irfc) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with newly diagnosed ...

No increased risk noted for prespecified outcomes, including preeclampsia or eclampsia, placental abruption, preterm birth, SGA ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

HealthDay News — Implementation of opt-out emergency department syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals, according to a study ...

At this time, the Company has not received any reports of adverse events related to this recall. Bionpharma, Inc. is recalling 1 lot of Atovaquone Oral Suspension, USP 750mg/5mL due to microbial ...